In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...

US$ 190 Billion By 2030. Insight On FDA Designated Orphan Drugs In Clinical Trials: > 850 Orphan Drugs. Clinical Trials ...

Beam Therapeutics (BEAM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...

Syndax now has two approved therapies, but the share price remains under pressure despite these milestones. See why SNDX ...

The GOP tax bill repeals the Inflation Reduction Act’s price controls for drugs for rare diseases.

In the past, if you had a question or curiosity about global norms, you'd probably talk it over with friends, family, or ...

If you’ve been prescribed metformin, it may be because you have prediabetes, type 2 diabetes, gestational diabetes, weight ...

Drug enforcement agencies across the nation play a crucial role in fighting the drug epidemic.The High Intensity Drug ...

In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of patients achieved stable ...

Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes ...

Zepbound is a prescription drug used to help with weight loss and sleep apnea in certain adults. The starting dosage for weight loss and sleep apnea is 2.5 mg injected once weekly for 4 weeks.